In addition, miR‐22 in vascular endothelial cells in NSCLC tissues directly targets sirtuin 1 and FGFR1, inactivating their common AKT/mTOR pathway to inhibit angiogenesis and tumor cell growth.161. Here, FGFR1 is linked to neoplasm.